Table 3.

Reasons for exclusion from this analysis of patients who achieved partial or complete remission at week 26

CsA Group (n)MMF/DEX Group (n)
Missing eGFR, UP/C, or medication information at week 52 or week 78102
Not on all prescribed study medications at week 5224
Nonstudy immunosuppressive drug (e.g., CsA, tacrolimus) given between week 52 and week 7850
Total176
  • CsA, cyclosporin A; MMF/DEX, mycophenolate mofetil/dexamethasone; eGFR, estimated GFR; UP/C, urinary protein/creatinine ratio.